Z-1923-2026 Class II Ongoing

Recalled by Remel Europe Ltd. — Dartford, N/A

FDA device recall Z-1923-2026 was initiated by Remel Europe Ltd. on Mar 25, 2026 and is designated Class II. Reason for recall: Affected lots are not performing to IFU criteria showing cross reactions with 2-0 within 60 seconds. Cross-reactivity may result in the misidentification of a Salmonella 9-O serotype as a 2-O… The recall status is ongoing. Affected quantity: 117 US; 950 OUS.

Recall details

Product Type
Devices
Report Date
Apr 29, 2026
Initiation Date
Mar 25, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
117 US; 950 OUS

Product description

Oxoid Agglutinating Sera, Salmonella 9-0 R30957301

Reason for recall

Affected lots are not performing to IFU criteria showing cross reactions with 2-0 within 60 seconds. Cross-reactivity may result in the misidentification of a Salmonella 9-O serotype as a 2-O serotype.

Distribution pattern

Worldwide - US Nationwide distribution to the states of AL, CA, FL, IA, IL, IN, MI, MN, MO, NC, NE, OH, SD, TX, WA.

Code information

UDI-DI 05056080500270 lots 6172600, 6172741, 6171393, 6150168, 6107767, 3766399, 3766400, 3780497, 3719592, 3709358, 6266130, 6253410, 6260215, 6222350, 6233859, 6233858

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1923-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1923-2026. Report a data issue: hello@regdatalab.com.